Wells Fargo & Company Soma Logic, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.76 - $2.83 $16,427 - $26,415	9,334 Added 20.7%	54,433 $137,000
Q3 2023 Nov 13, 2023	SELL	$1.99 - $2.45 $42,148 - $51,891	-21,180 Reduced 31.96%	45,099 $107,000
Q2 2023 Aug 15, 2023	BUY	$2.1 - $3.36 $62,836 - $100,537	29,922 Added 82.3%	66,279 $153,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.6 $58,966 - $99,662	27,684 Added 319.2%	36,357 $92,000
Q4 2022 Feb 13, 2023	SELL	$2.05 - $3.47 $1,404 - $2,376	-685 Reduced 7.32%	8,673 $21,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $919 - $7,986	-1,460 Reduced 13.5%	9,358 $27,000
Q2 2022 Aug 12, 2022	SELL	$4.27 - $8.26 $3,095 - $5,988	-725 Reduced 6.28%	10,818 $49,000
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $21 - $34	3 Added 0.03%	11,543 $93,000
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $89,584 - $121,951	8,540 Added 284.67%	11,540 $134,000
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $29,820 - $38,310	3,000 New	3,000 $37,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.